NDAINHALATIONGAS
Approved
Aug 2013
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
7
Data completeness
3/8 — Basic
NITROGEN, NF (nitrogen) by Advanced Solutions Life Sciences. Approved for critical illness, nutrition therapy, postoperative complications and 7 more indications. First approved in 2013.
Drug data last refreshed 21h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NITROGEN, NF is a pharmaceutical-grade nitrogen gas administered via inhalation for therapeutic use across multiple clinical indications. It is indicated for critical illness, nutrition therapy, postoperative complications, gastrointestinal neoplasms, basal cell carcinoma, hepatitis C, bronchopulmonary dysplasia, hypoxia, tinea, and warts. The mechanism of action and pharmacologic class are undefined, suggesting this is a supportive care or adjunctive therapeutic gas.
Peak
Product is in peak commercial stage; team size and support likely stable, but broad indication portfolio may indicate smaller specialized sales force or hospital-focused model.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on NITROGEN, NF at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.